| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3901327
Max Phase: Preclinical
Molecular Formula: C19H22FN3O
Molecular Weight: 327.40
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CC1(C)CC1(C(=O)NCCNc1cccnc1)c1ccc(F)cc1
Standard InChI: InChI=1S/C19H22FN3O/c1-18(2)13-19(18,14-5-7-15(20)8-6-14)17(24)23-11-10-22-16-4-3-9-21-12-16/h3-9,12,22H,10-11,13H2,1-2H3,(H,23,24)
Standard InChI Key: YJVQXYTVXOAJAE-UHFFFAOYSA-N
Associated Targets(non-human)
Lipoprotein lipase 268 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 327.40 | Molecular Weight (Monoisotopic): 327.1747 | AlogP: 3.12 | #Rotatable Bonds: 6 |
| Polar Surface Area: 54.02 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 5.54 | CX LogP: 2.45 | CX LogD: 2.44 |
| Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.80 | Np Likeness Score: -0.92 |
References
| 1. Geldenhuys WJ, Caporoso J, Leeper TC, Lee YK, Lin L, Darvesh AS, Sadana P.. (2017) Structure-activity and in vivo evaluation of a novel lipoprotein lipase (LPL) activator., 27 (2): [PMID:27913180] [10.1016/j.bmcl.2016.11.053] |
Source
Source(1):